Adult ID

Epi/Infection Control

Oral Abstract

296 - New Insights into MDRO Gram-Negatives

Presentations:

• 1:45 PM - 2:00 PM

  2848 - Spatial Distribution of Community-Acquired Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections and its Association With Sewer Overflows in Middle Georgia
  Margaret Omatsone, MD – Medical Center of Central Georgia, Navicent Health, Macon GA; Rafael Ponce-Terashima, MD – Medical Center of Central Georgia, Navicent Health, Macon GA; Thomas Cole Baker, MD – Medical Center of Central Georgia, Navicent Health, Macon GA
• 2:00 PM - 2:15 PM

  2849 - Gut Microbiota Differences at the Time of Medical Intensive Care Unit (MICU) Admission Are Associated with Acquisition of Multidrug-Resistant Organisms (MDROs) among Patients Not Already Colonized with an MDRO
  Christine Bassis, PhD – University of Michigan; Anna Seekatz, PhD – Clemson University; Thelma E. Dangana, MBBS – Rush University Medical Center; Teppei Shimasaki, MD, MS – Rush University Medical Center; Rachel D. Yelin, MPH – Rush University Medical Center; Michael Schoeny, PhD – Rush University Medical Center; Yoona Rhee, MD, ScM – Rush University Medical Center; Michelle Ariston, BS – Rush University Medical Center; Karen Lolans, BS – Rush University Medical Center; Enrique Cornejo Cisneros, MD, MS – Rush University Medical Center; Khaled Aboushaala, MD – Rush University Medical Center; Lina Thabit, MBBS, MS – Rush University Medical Center; John Murray, MS – Rush University Medical Center; Jianrong Sheng, MD, PhD – Rush University Medical Center; Stefanie Ollison, BS – Rush University Medical Center; Pamela B. Bell, II, BA – Rush University Medical Center; Louis Fogg, PhD – Rush University Medical Center; Robert A. Weinstein, MD – Rush University Medical Center; Michael Y. Lin, MD, MPH – Rush University Medical Center; Vincent B. Young, MD, PhD – University of Michigan; Mary K. Hayden, MD – Rush University Medical Center
• 2:15 PM - 2:30 PM

  2850 - Burden of Difficult-to-Treat Antibiotic-Resistant (DTR) Gram-negative Infections in the United States, 2012-2017
  Sameer S. Kadri, MD, MS – National Institutes of Health; James Baggs, PhD – Centers for Disease Control and Prevention; Sarah H. Yi, PhD, MS – Centers for Disease Control and Prevention; Jeffrey R. Strich, MD – National Institutes of Health; Yi Ling Lai, MPH – National Institute of Allergy and Infectious Diseases; Emily Ricotta, PhD, ScM – National Institute of Allergy and Infectious Diseases; D. Rebecca Prevots, PhD – National Institute of Allergy and Infectious Diseases; Robert L. Danner, MD – National Institutes of Health; Hannah Wolford, MSPH – Centers for Disease Control and Prevention; Babatunde Olubajo, PhD, MPH – Centers for Disease Control and Prevention; Kelly M. Hatfield, MSPH – Centers for Disease Control and Prevention; Sujan Reddy, MD, MSc – Centers for Disease Control and Prevention; John A. Jernigan, MD, MS – Centers for Disease Control and Prevention
• 2:30 PM - 2:45 PM

  2851 - Impact of Antimicrobial Resistant Gram-Negative Bloodstream Infections on Outcomes among Pediatric Hospitalizations in the United States, 2009-2016
  Alicen B. Spaulding, PhD, MPH – Children's Minnesota Research Institute; David Watson, PhD – Children's Minnesota Research Institute; Jill Dreyfus, PhD, MPH – Premier, Inc.; Phillip Heaton, PhD – Children's Minnesota Research Institute; Anupam Kharbanda, MD, MS – Children's Minnesota Research Institute
• 2:45 PM - 3:00 PM

  2852 - Epidemiology of Emerging Carbapenemase-Producing Organisms (CPO) in Chicago, Illinois, 2013-2018
  Massimo Pacilli, MS, MPH – Chicago Department of Public Health; Hira Adil, MD, MPH – City of Chicago; Kelly Walblay, MPH – Chicago Department of Public Health; Shannon N. Xydis – Chicago Department of Public Health; Whitney Clegg, MD – Chicago Department of Public Health; Michael Y. Lin, MD, MPH – Rush University Medical Center; Ann M. Valley, BS – WISCONSIN STATE LAB OF HYGIENE; Angela Tang, MPH – Illinois Department of Public Health; Amy E. Fealy, MPH – Hektoen Institute of Medicine; Sarah K. Kemble, M.D. – Chicago Department of Public Health; Stephanie R. Black, MD, MSc – Chicago Department of Public Health

Co-Author(s)

• MP

  Massimo Pacilli, MS, MPH

  Manager of Quality Assurance, Laboratory Liaison
  Chicago Department of Public Health
  Chicago, IL

  Disclosure: Nothing to disclose
• HA

  Hira Adil, MD, MPH

  Public health administrator II
  City of Chicago
  Chicago, IL

  Disclosure: Nothing to disclose
• JB

  James Baggs, PhD

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• RP

  Rafael Ponce-Terashima, MD

  Infectious Disease Consultant
  Medical Center of Central Georgia, Navicent Health, Macon GA
  Macon, GA

  Disclosure: Nothing to disclose
• AS

  Anna Seekatz, PhD

  Dr.
  Clemson University
  Clemson, SC

  Disclosure: Nothing to disclose
• DW

  David Watson, PhD

  Biostatistician
  Children's Minnesota Research Institute
  Minneapolis, MN

  Disclosure: Nothing to disclose
• TB

  Thomas Cole Baker, MD

  Medical Student
  Medical Center of Central Georgia, Navicent Health, Macon GA
  Macon, GA

  Disclosure: Nothing to disclose
• TD

  Thelma Dangana, MBBS

  Coordinator
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• JD

  Jill Dreyfus, PhD, MPH

  Principal
  Premier, Inc.
  Charlotte, NC

  Disclosure: Premier Inc: Employee, Shareholder
• KW

  Kelly Walblay, MPH

  HAI-Epidemiologist
  Chicago Department of Public Health
  Chicago, IL

  Disclosure: Nothing to disclose
• 

  Sarah H. Yi, PhD, MS

  Health Scientist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• PH

  Phillip Heaton, PhD

  Clinical Microbiologist
  Children's Minnesota Research Institute
  Minneapolis, MN

  Disclosure: Nothing to disclose
• TS

  Teppei Shimasaki, MD, MS

  Dr.
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• JS

  Jeffrey Strich, MD

  Staff Clinician
  National Institutes of Health
  Bethesda, MD

  Disclosure: Nothing to disclose
• SX

  Shannon Xydis

  Projects Administrator, HAI Coordinator
  Chicago Department of Public Health
  Chicago, IL

  Disclosure: Nothing to disclose
• WC

  Whitney Clegg, MD

  Epidemiologist
  Chicago Department of Public Health
  Chicago, IL

  Disclosure: Nothing to disclose
• AK

  Anupam Kharbanda, MD, MS

  Chief of Critical Care Service
  Children's Minnesota Research Institute
  Minneapolis, MN

  Disclosure: Nothing to disclose
• YL

  Yi Ling Lai, MPH

  Data Manager
  National Institute of Allergy and Infectious Diseases
  Bethesda, MD

  Disclosure: Nothing to disclose
• RY

  Rachel Yelin, MPH

  Ms.
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• 

  Michael Lin, MD, MPH

  Associate Professor
  Rush University Medical Center
  Chicago, IL

  Disclosure: CareFusion Foundation (BD): Investigator-initiated grant, Other Financial or Material Support
  OpGen: Other Financial or Material Support, Research support in the form of contributed product
  Sage Products (now part of Stryker): Other Financial or Material Support, Research support in the form of contributed product
• ER

  Emily Ricotta, PhD, ScM

  Epidemiologist, Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research
  National Institute of Allergy and Infectious Diseases
  Bethesda, MD

  Disclosure: Nothing to disclose
• MS

  Michael Schoeny, PhD

  Associate Professor
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• DP

  D. Rebecca Prevots, PhD

  Head, Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research
  National Institute of Allergy and Infectious Diseases
  Bethesda, MD

  Disclosure: Nothing to disclose
• YR

  Yoona Rhee, MD, ScM

  Assistant Professor
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• AV

  Ann Valley, BS

  Microbiologist
  WISCONSIN STATE LAB OF HYGIENE
  Madison, WI

  Disclosure: Nothing to disclose
• MA

  Michelle Ariston, BS

  Ms.
  Rush University Medical Center
  Chicago, IL

  Disclosure: Abbott Diagnostics: Employee
• RD

  Robert Danner, MD

  Senior Investigator
  National Institutes of Health
  Bethesda, MD

  Disclosure: Nothing to disclose
• AT

  Angela Tang, MPH

  Healthcare-Associated Infections Epidemiologist
  Illinois Department of Public Health
  Chicago, IL

  Disclosure: Nothing to disclose
• AF

  Amy Fealy, MPH

  Epidemiologist
  Hektoen Institute of Medicine
  Chicago, IL

  Disclosure: Nothing to disclose
• KL

  Karen Lolans, BS

  Lab Research Assistant II
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• HW

  Hannah Wolford, MSPH

  Scientific Data Analyst
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• EC

  Enrique Cornejo Cisneros, MD, MS

  Infectious diseases physician
  Rush University Medical Center
  Lima, Lima, Peru

  Disclosure: Nothing to disclose
• SK

  Sarah Kemble, M.D.

  Medical Director
  Chicago Department of Public Health
  Honolulu, HI

  Disclosure: Nothing to disclose
• BO

  Babatunde Olubajo, PhD, MPH

  Principal Health Research Analyst
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• KA

  Khaled Aboushaala, MD

  Researcher
  Rush University Medical Center
  Naperville, IL

  Disclosure: Nothing to disclose
• KH

  Kelly Hatfield, MSPH

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• 

  Sujan Reddy, MD, MSc

  Medical Director of CDC’s Prevention Epicenter Program
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• LT

  Lina Thabit, MBBS, MS

  Dr
  Rush University Medical Center
  Burlington, ON, Canada

  Disclosure: Nothing to disclose
• JJ

  John Jernigan, MD, MS

  Director, Office of Prevention Research and Evaluation
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• JM

  John Murray, MS

  Mr.
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• JS

  Jianrong Sheng, MD, PhD

  Dr.
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• SO

  Stefanie Ollison, BS

  Ms.
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• PB

  Pamela Bell, II, BA

  Lab Research Tech III
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• LF

  Louis Fogg, PhD

  Dr.
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• RW

  Robert Weinstein, MD

  Professor
  Rush University Medical Center
  Chicago, IL

  Disclosure: Nothing to disclose
• 

  Michael Lin, MD, MPH

  Associate Professor
  Rush University Medical Center
  Chicago, IL

  Disclosure: CareFusion Foundation (BD): Investigator-initiated grant, Other Financial or Material Support
  OpGen: Other Financial or Material Support, Research support in the form of contributed product
  Sage Products (now part of Stryker): Other Financial or Material Support, Research support in the form of contributed product
• 

  Vincent Young, MD, PhD

  William Henry Fitzbutler Collegiate Professor
  University of Michigan
  Ann Arbor, MI

  Disclosure: Bio-K+ International: Consultant
  Pantheryx: Consultant
  Vedanta Biosciences: Consultant
• MH

  Mary Hayden, MD

  Chief, Division of Infectious Diseases; Director, Division of Clinical Microbiology, Professor of Medicine and Pathology
  Rush University Medical Center
  Chicago, Illinois

  Disclosure: Clorox: Grant/Research Support, Other Financial or Material Support, I am co-investigator on research projects at healthcare facilities where Clorox provides product at no cost. Neither I nor my institution receive product.
  Medline: Other Financial or Material Support, I am co-investigator on research projects at healthcare facilities where Medline provides product at no cost. Neither I nor my institution receive product.
  Molnlycke: Other Financial or Material Support, I am co-investigator on research projects at healthcare facilities where Molnlycke provides product at no cost. Neither I nor my institution receive product.
  OpGen: Other Financial or Material Support, I am co-investigator on research projects at healthcare facilities where Sage provides laboratory services at no cost. Neither I nor my institution receive services.
  Sage: Other Financial or Material Support, I am co-investigator on research projects at healthcare facilities where Sage provides product at no cost. Neither I nor my institution receive product.

Moderator(s)

• 

  Michael Lin, MD, MPH

  Associate Professor
  Rush University Medical Center
  Chicago, IL

  Disclosure: CareFusion Foundation (BD): Investigator-initiated grant, Other Financial or Material Support
  OpGen: Other Financial or Material Support, Research support in the form of contributed product
  Sage Products (now part of Stryker): Other Financial or Material Support, Research support in the form of contributed product
• LM

  L Silvia Munoz-Price, MD, PhD

  Professor of Medicine
  Medical College of Wisconsin
  Milwaukee, WI

  Disclosure: Nothing to disclose

Presenting Author(s)

• CB

  Christine Bassis, PhD

  Dr.
  University of Michigan
  Ann Arbor, MI

  Disclosure: Nothing to disclose
• SK

  Sameer Kadri, MD, MS

  Head, Clinical Epidemiology Section, Critical Care Medicine Department
  National Institutes of Health
  Bethesda, MD

  Disclosure: Nothing to disclose
• MO

  Margaret Omatsone, MD

  Fellow
  Medical Center of Central Georgia, Navicent Health, Macon GA
  Macon, GA

  Disclosure: Nothing to disclose
• AS

  Alicen Spaulding, PhD, MPH

  Scientific Investigator
  Children's Minnesota Research Institute
  Minneapolis, MN

  Disclosure: Nothing to disclose
• SB

  Stephanie Black, MD, MSc

  Medical Director, Communicable Diseases Program
  Chicago Department of Public Health
  Chicago, IL

  Disclosure: Nothing to disclose